Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery
Clinical trial NCT02855086 · TERMINATED
Trial details
- NCT number
- NCT02855086
- Sponsor
- Eben Rosenthal
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2016-11-08
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.